Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;14(1):22-34.
doi: 10.1007/s44197-024-00190-z. Epub 2024 Mar 11.

Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis

Affiliations
Review

Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis

Mehdi Bamorovat et al. J Epidemiol Glob Health. 2024 Mar.

Abstract

Leishmaniasis is a disease of poverty that imposes a devastating medical, social, and economic burden on over 1 billion people nationwide. To date, no in-depth study to analyze the major global challenges and needs assessment has been carried out. This investigation aimed to explore a comprehensive narrative review of leishmaniasis's main challenges and initially highlight obstacles that might impede the implementation of control measures. Also, we propose a specific list of priorities for needs assessment. The presence of socioeconomic factors, multiple clinical and epidemiological forms, various Leishmania species, the complexity of the life cycle, the absence of effective drugs and vaccines, and the lack of efficient vector and reservoir control make this organism unique and sophisticated in playing a tangled role to react tricky with its surrounding environments, despite extensive efforts and implementation of all-inclusive former control measures. These facts indicate that the previous strategic plans, financial support, and basic infrastructures connected to leishmaniasis surveillance are still insufficient. Strengthening the leishmaniasis framework in a context of accelerated programmatic action and intensification of cross-cutting activities along with other neglected tropical diseases (NTDs) is confidently expected to result in greater effectiveness, cost-benefit, and fruitful management. Sensitive diagnostics, effective therapeutics, and efficacious vaccines are vital to accelerating advancement toward elimination, and reducing morbidity/mortality and program costs. Collective actions devoted by all sectors and policy-makers can hopefully overcome technical and operational barriers to guarantee that effective and coordinated implementation plans are sustained to meet the road map for NTDs 2021- 2030 goals.

Keywords: Control strategies; Development goals; Leishmaniasis challenges; Needs assessment.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare that are relevant to the content of this article.

Figures

Fig. 1
Fig. 1
Global distribution of four eco-epidemiological forms of leishmaniasis: A zoonotic cutaneous leishmaniasis (ZCL), B anthroponotic CL (ACL), C zoonotic visceral leishmaniasis (ZVL), and D anthroponotic VL (AVL)
Fig. 2
Fig. 2
Significant challenges for achieving sustainable development goals (control, elimination, and eradication)
Fig. 3
Fig. 3
Needs assessment for achieving sustainable development goals in leishmaniasis. Extensive and long-term integrated efforts are desperately needed to attain the above targets through cross-cutting activities and accelerating programmatic actions to control, eliminate, and eradicate neglected tropical diseases (NTDs) including leishmaniasis. The plan requires necessary resources to prepare the infrastructure, and the required costs for the implementation of long-lasting preventive and therapeutic measures including the diagnostic kits, essential drugs, and personnel expenses for coordinating, integrating, mainstreaming, and strengthening health systems to leishmaniasis interventions across health and nonhealth sectors

Similar articles

  • Tuberculosis.
    Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
  • The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, Chiles TC, Donohue MJ, Enck J, Fenichel P, Fleming LE, Ferrier-Pages C, Fordham R, Gozt A, Griffin C, Hahn ME, Haryanto B, Hixson R, Ianelli H, James BD, Kumar P, Laborde A, Law KL, Martin K, Mu J, Mulders Y, Mustapha A, Niu J, Pahl S, Park Y, Pedrotti ML, Pitt JA, Ruchirawat M, Seewoo BJ, Spring M, Stegeman JJ, Suk W, Symeonides C, Takada H, Thompson RC, Vicini A, Wang Z, Whitman E, Wirth D, Wolff M, Yousuf AK, Dunlop S. Landrigan PJ, et al. Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
  • Innovation in neglected tropical disease drug discovery and development.
    Weng HB, Chen HX, Wang MW. Weng HB, et al. Infect Dis Poverty. 2018 Jun 18;7(1):67. doi: 10.1186/s40249-018-0444-1. Infect Dis Poverty. 2018. PMID: 29950174 Free PMC article. Review.
  • Review of the neglected tropical diseases programme implementation during 2012-2019 in the WHO-Eastern Mediterranean Region.
    Warusavithana S, Atta H, Osman M, Hutin Y. Warusavithana S, et al. PLoS Negl Trop Dis. 2022 Sep 29;16(9):e0010665. doi: 10.1371/journal.pntd.0010665. eCollection 2022 Sep. PLoS Negl Trop Dis. 2022. PMID: 36173943 Free PMC article. Review.
  • Neglected tropical diseases: an effective global response to local poverty-related disease priorities.
    Engels D, Zhou XN. Engels D, et al. Infect Dis Poverty. 2020 Jan 28;9(1):10. doi: 10.1186/s40249-020-0630-9. Infect Dis Poverty. 2020. PMID: 31987053 Free PMC article. Review.

Cited by

References

    1. Bailey F, Mondragon-Shem K, Hotez P, Ruiz-Postigo JA, Al-Salem W, Acosta-Serrano Á, et al. A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis. 2017;11:e0005739. doi: 10.1371/journal.pntd.0005739. - DOI - PMC - PubMed
    1. WHO. WHO to implement online epidemiological surveillance for leishmaniasis. Available [Http://WwwWhoInt/Neglected_diseases/News/WHO_implement_epidemiological_surveillance_leishmaniasis/En] 2016.
    1. WHO. Leishmaniasis, Status of endemicity of cutaneous leishmaniasis: 2019. 2020–06–15)[2020–09–08] Https//Apps Who Int/Neglected_diseases/Ntddata/Leishmaniasis/Leishmaniasis Html 2019.
    1. Bamorovat M, Sharifi I, Afshari SAK, Karamoozian A, Tahmouresi A, Heshmatkhah A, et al. Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: a case-control field assessment in Iran. Int J Parasitol Drugs Drug Resist. 2023;21:21–27. doi: 10.1016/j.ijpddr.2022.11.006. - DOI - PMC - PubMed
    1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671. doi: 10.1371/journal.pone.0035671. - DOI - PMC - PubMed